Cloruro Sódico Y Cloruro Potásico Baxter

Cloruro Sódico Y Cloruro Potásico Baxter is an injectable solution that combines sodium chloride and potassium chloride. It is supplied as a sterile intravenous solution intended for electrolyte replacement and fluid balance. The product is manufactured for the EU market and requires a prescription. It delivers essential sodium and potassium ions to help restore plasma osmolarity and support normal cellular function.

Cloruro Sódico Y Cloruro Potásico Baxter is used in clinical settings to correct electrolyte disturbances and support fluid management. It is commonly administered when patients need rapid restoration of sodium and potassium levels.

- Treatment of hyponatremia caused by sodium loss or dilution - Management of hypokalemia resulting from inadequate potassium intake - Fluid replacement during surgery or major trauma - Support of electrolyte balance in patients receiving diuretics - Maintenance of plasma osmolarity in critically ill patients

Side effects of Cloruro Sódico Y Cloruro Potásico Baxter may vary in frequency and severity. Monitoring during infusion helps identify and manage any adverse reactions.

Common: - Mild local irritation at the injection site - Transient nausea or vomiting - Temporary headache or dizziness

Serious: - Hypernatremia or hyperkalemia leading to cardiac arrhythmias - Severe allergic reaction such as anaphylaxis - Rapid rise in blood pressure or fluid overload

When using Cloruro Sódico Y Cloruro Potásico Baxter, clinicians should consider several safety factors to minimize risks.

- Verify patient electrolyte levels before and during infusion - Adjust infusion rate in patients with renal impairment - Avoid use in individuals with known hypersensitivity to sodium or potassium salts - Monitor cardiac rhythm in patients with pre‑existing heart disease - Use caution in patients with fluid overload or congestive heart failure - Ensure proper aseptic technique to prevent infection

Cloruro Sódico Y Cloruro Potásico Baxter can interact with other medications that affect electrolyte balance or cardiac function. Awareness of these interactions helps prevent complications.

Avoid: - Concurrent use of high‑dose potassium‑sparing diuretics (e.g., spironolactone) that may cause hyperkalemia - Administration with other hypertonic saline solutions that could raise sodium levels excessively - Co‑administration with ACE inhibitors or ARBs that may increase potassium retention

Use with caution: - Concomitant use of digitalis glycosides, as electrolyte shifts can precipitate toxicity - Simultaneous infusion of other intravenous fluids; adjust rates to avoid fluid overload